General Information of the Compound
Compound ID
CP0385714
Compound Name
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine
    Show/Hide
Structure
Formula
C14H13N3O3S
Molecular Weight
303.343
Canonical SMILES
COc1ccc(cc1)S(=O)(=O)n1c(N)nc2ccccc12
    Show/Hide
InChI
InChI=1S/C14H13N3O3S/c1-20-10-6-8-11(9-7-10)21(18,19)17-13-5-3-2-4-12(13)16-14(17)15/h2-9H,1H3,(H2,15,16)
    Show/Hide
InChIKey
HPRFQHGWMAWFQS-UHFFFAOYSA-N
Physicochemical Property
logP
1.8641
Rotatable Bonds
3
Heavy Atom Count
21
Polar Areas
87.21
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44229066
SID: 134967762
ChEMBL ID
CHEMBL1316316
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01446, Interleukin-8
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000892 MCF-7/NOD1 Homo sapiens (Human)  2
1
IC50 = 3130 nM
   TI
   LI
   LO
   TS
2
IC50 > 5000 nM
   TI
   LI
   LO
   TS
CL000797 MCF-7/NOD2 Homo sapiens (Human)  1
1
IC50 > 5000 nM
   TI
   LI
   LO
   TS
Protein ID: PT03645, Nucleotide-binding oligomerization domain-containing protein 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 2700 nM
   TI
   LI
   LO
   TS
Protein ID: PT03970, Nucleotide-binding oligomerization domain-containing protein 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS